Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG‐N0377, Alliance)
- Citation:
- Oncologist vol 23 (8) 887-e94
- Year:
- 2018
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 7
- Parents:
- 545
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U10CA180790
- Corr. Author:
- Authors:
- Jesus Vera Aguilera Ravi D. Rao Jacob B. Allred Vera J. Suman Harold E. Windschitl Judith S. Kaur William J. Maples Val J. Lowe Edward T. Creagan Lori A. Erickson Svetomir Markovic
- Networks:
- IA094, LAPS-MN026
- Study
- NCCTG-N0377
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: